Skip to main content
. 2022 Jun 1;13(7):1016–1029. doi: 10.1021/acsmedchemlett.1c00662

Table 4. Leading Cutting-Edge AI/ML-Based Organizations Providing Innovation in Drug Discovery.

vendor application CI SBDD main function Web site
Exscientiaa Centaur Chemist uses AI to learn best-practices from drug discovery data and experienced drug hunters https://www.exscientia.ai/
 
Insilico Medicine Chemistry42 AI/DL generative platform for de novo drug design https://insilico.com/chemistry42
 
Atomwisea Services Options utilizes deep-learning AI technology for structure-based small-molecule drug discovery. https://www.atomwise.com/ (ref (74))
 
Cyclica Ligand Design, Ligand Express apply a combination of computational biophysics and ML to design novel drugs https://www.cyclicarx.com/ (ref 75)
 
XtalPi RENOVA generate novel drug-like molecules by combining QM and AI; predict crystal formation of small molecules https://www.xtalpi.com/en/
 
Recursion ReChem, RePredict, ReAnalyze develop novel chemical compounds by utilizing AI to conduct experimental biology, at scale, by testing thousands of compounds on hundreds of cellular disease models in parallel https://www.recursion.com/
 
IBMa Generative Models develop new AI methods for de novo compound generation as well as methods for retrosynthetic analysis to accelerate drug discovery https://research.ibm.com/science/generative-models/
 
1910 Geneticsa ELVIS, ROSALYND discover new drugs using computation, physics, and ML; develop a robust in silico platform utilizing AI/ML methods https://1910genetics.com/
 
Insitroa   Insitro is a drug discovery and development startup that utilizes ML and biology to transform drug discovery https://insitro.com/
 
OneThree Biotecha   combining systems biology with AI to uncover new insights and build next-generation drug discovery https://onethree.bio/ (ref (76))
 
Iktos Makya, Spaya AI/DL platforms for generative de novo drug design and retrosynthetic analysis https://iktos.ai/
 
DeepMind AlphaFold   uses AI to accelerate drug discovery; discovered one of the most successful protein structure prediction algorithms, Alphafold 2.0 https://deepmind.com/
 
ACELLERA PlayMolecule one-click molecular discovery platform consisting of innovative MD- and DL-based tools that transcend the drug discovery continuum design paradigm https://www.acellera.com/products/playmolecule/
 
Glamorous AI (now X-Chem) ROSALINDAI SaaS platform for AI/ML-based drug discovery; largest repository of state-of-the-art AI/ML-based models employed for applications including de novo generative design https://www.glamorous.ai/rosalindai
 
BenevolentAIa The Benevolent Platform knowledge graph-based platform for drug discovery https://www.benevolent.com/
a

Drug discovery companies which may not offer access to AI/ML tools and applications.